When treating obesity, semaglutide may be associated with a reduced fracture risk compared with sleeve gastrectomy.

For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can naturally mimic the effects of semaglutides.

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide, more individuals are exploring their potential health benefits ...

Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (sold as Ozempic or Wegovy), mimic ... gene expression that are not attributable to modification of the DNA sequence itself.

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...